- Home
- MRVI
as 02-21-2025 4:00pm EST
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Upcoming Earnings Alert:
Get ready for potential market movements as Maravai LifeSciences Holdings Inc. MRVI prepares to release earnings report on 25 Feb 2025.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 795.7M | IPO Year: | 2020 |
| Target Price: | $10.28 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.93 - $11.56 | Next Earning Date: | 02-25-2025 |
| Revenue: | $276,920,000 | Revenue Growth: | -33.99% |
| Revenue Growth (this year): | -8.18% | Revenue Growth (next year): | 1.93% |
Latest Maravai LifeSciences Holdings Inc. News
MRVI Breaking Stock News: Dive into MRVI Ticker-Specific Updates for Smart Investing
Business Wire
18 days ago
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
MT Newswires
19 days ago
Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA
Business Wire
19 days ago
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
MT Newswires
25 days ago
Maravai Lifesciences Acquires Molecular Assemblies' Intellectual Property, Related Assets
Business Wire
25 days ago
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Simply Wall St.
a month ago
Three Top Undervalued Small Caps In US With Insider Buying
Insider Monkey
a month ago
Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential
MT Newswires
a month ago
Maravai Lifesciences Reports Preliminary 2024 Revenue; Shares Fall After Hours
Compare MRVI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRVI Maravai LifeSciences Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.